Inmunopatogénesis de la Diabetes 1

Bach J.F.: ¡nsulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542, 1994.

Eisenbarth G.S.: Molecular aspects of the etiology of type I diabetes mellitus. Journal of Diabetes and its implications 7:142-150,1993.

Arnush M. et al: Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J. Clin. Inves!. 102:2684-2691, 1998.

Mandrup-Poulsen et al: Cytokines and the endocrine system. 11. Roles in substrate metabolism, modulation ofthyroidal and

pancreatic endocrine cell functions and autoimmune endocrine diseases. Eur. Journal of Endocrinology 134:21-30, 1996.

Yamada K. et al: Mouse islet celllysis mediated by interleukin- 1-induced Fas. Diabetologia 39:1306-1312,1996.

Rose N.R., Bona C.: Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today 14: 426-430, 1993.

Rotter J.I., Valdheim C.M., Rimoin D.L.: Genetics of diabetes mellitus. In Rifkin H., Porte D (eds) Diabetes Mellitus. Theory and practice 4. Elsevier, Amsterdam, pp. 378-413, 1990.

Thomson Gabriel: Mapping disease genes: Family-based association studies. Am. J. Hum. Gene!. 57:487-498, 1995

Lo S.S., Tun RY., Hawa M., Leslie RD: Studies of diabetic twins. Diabetes Metab. Rev 7:223-238, 1999.

Laakso M., ReunanenA., Klaukka T., et al: Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am. J. Epidemiol. 133:850-857, 1991.

Songini M., Muntoni S.: High incidence of type I diabetes in Sardinia, Lancet 337:1047,1991.

King M.L., Shaiakh A., Bidwell D. et al: Coxsackie-B-virus-specific IgM responses in children with insulin dependent Uuvenileonset;

type 1) diabetes mellitus. Lancet 1: 1397-1399, 1983.

Kaufman D.L., Erlander M.G., Clare-Salzler M., et al: Autoimmunity to two forms of glutamate decarboxylase in ¡nsulin-dependent

diabetes mellitus. J. Clin. Inves!. 89:283-292, 1985.

Elliot RB., Martin J.M: Dietary proteins: a trigger of insulin-dependent diabetes in the BB rat? Diabetologia 26:297-299, 1984.

Corbett JA, Wang J.L, et al: Interleukin 1b induces the formation of nitric oxide by B-cells purified from rodent islets of Langerhans. J. Clin. Inves!. 90:2384-2391, 1992.

Rose N.R: Autoimmune Diseases: Tracing the shared threads. Hospital Practice. 1997.

Lacy P.E: The intraislet macrophage and type I diabetes. The Mount Sinai Journal of Medicine 61(2):170-174,1994.

Lee W.C., Zhong C., Quian S. et al: Phenotype function and in vivo migration and survival of allogenic dendritic cell progenitors

genetically engineered to express TGF-b. Transplantation 66:1810-1817,1998.

Bendtzen K., Mandrup-Poulsen T., et al: Cytotoxicity of human interleukin-1 or pancreatic islets of Langerhans. Science 232:1545-1547,1986.

Hanenberg H., Kolb-Bachofen, Kantwerk-Funke G., Kolb H.: Macrophage infiltration precedes and is prerequisite for Iymphocytic

insulilis in pancreatic islets of prediabetic BB rats. Diabetologia 32: 126-134, 1989.

Yagi N., Yokono K., Amano K. et al: Expression of intercellular adhesion molecule 1 on pancreatic b-cells destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes

:744-751,1995.

Harrison L.C., Chu S.X., de Aixpurua H.J., et al: Islet reactive T celis are a marker of preclinical insulin-dependent diabetes. J. Clin. Inves!. 89: 1161-1165, 1992.

Haskins K., McDuffie M.: Acceleration of diabetes in young NaD mice with a CD4+ islet-specific T-cell clone. Science 249:1433-1436,1990.

Garcia K.C., Teyton L., Wilson lA: Structural basis ofT-cell recognition. Annu. Rev. Immunol. 17:369-397, 1999.

Moretta A., Biassoni R., Bottino C. et al: Major histocompatibility complex class I-specific receptors on human natural killer and T Iyrnphocytes. Immunol. Rev. 155:105-117, 1997

Mag W.J., Bersani L. and Mantovani A.: Tumor necrosis factor is chemotactic for mOhocytes and polymorpholeucocytes. J. Immunol. 138:1069, 1997.

Weber M., Deng S. et at: Adenoviral transfection of isolated pancreatic islets:A study of programmed cell death (Apoptosis) and islet function. Journal of Surgical Research 69:23-32, 1997.

Kanets H., Fuji J., Seo H., et al: Apoptopic cell death triggered by nitric oxide in pancreatic ~ cells. Diabetes 44:733, 1995. 29. McDaniel M.L., Kwon G., et al: Cy10kines and nitric oxide in islet inflammation and diabetes. Proc. Soco Exp. Biol. Med. 211:24-32, 1996.

Corbett J.A., et al: Nitric oxide mediates 11-1b-1 induced islet dysfunction and destruction: Prevention by dexamethasone. Autoimmunity 15:145-153, 1993.

Dahlen E., Dawe K. et al. Dendritic cells and macrophages are the first and major producers of TNF-a in pancreatic islets in the nonobese diabetic mouse. Journal of Immunology 160:3585-3593, 1998.

Baldwin A.S. Jr.: The NF-kappa B and 1kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649- 683, 1996.

Giannoukakis N., Rudert WA., Robbins P. and Trucco M.: Targeting autoimmune diabetes with gene therapy. Diabetes 48:2107-21211, 1999.

Suda T, Takahashi T. et al: Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factorfamily. CeIl75:1169-1178, 1993.

Suda T, Hashimoto H. et al: Membrane fas ligand kills human peripheral blood T Iymphocytes, and soluble fas ligand blocks the killing. J. Exped. Med. 186(12):2045-2050, 1997

Hale AJ., Smith C.A. et al: Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236:1-26,1996.

Scarim AL., Arnush M. et al: Evidence for the presence of type I IL-1 receptors on b-cells of islets of Langerhans. Biochimica et Biophysica Aeta 1361 :313-320, 1997.

Kagi D., Vignaux F. et al: Fas and perforing pathways as major mechanisms of T Cell-mediated cytotoxicity. Science 265:528-530,1994.

Trauth B.C., Klas C. et al: Monoclonal antbody-mediated tumor regression by inductionof apoptosis.Science 245:301-305,1989.

Shigekazu N. and Suda T: Fas and fas ligand: Ipr and gld mutations. Immunol. Today 16(1):39-43, 1995.

Stassi G. et al: Nitric oxide primes pancreatic b cells for fasmediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193-1200, 1997.

PosseltAM., Naji A., Roark J.H., et al: Intrathymic islet transplantation in the spontaneously diabetic BB rat. Ann. Surg. 214:363-373,1991.

Charlton B., Taylor-Edwards C., Tisch R, Fathman C.G: Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J.Autoimmun. 7:549-560,1994.

Arnush M., Scarim A.L. et al: Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J. Immunol. 160:2684-2691, 1998.

Hunger RE., Carnaud C., Garcia l., Vasalli P., Mueller C: Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur. J. Immunol. 27:255-261, 1997.

Thomson AW, Lu L., et al: Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem. CeI113:622- 639,1995.

Lenschow D.J., Zeng 1.et at: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789-792,1992.

Weber C.J., Hagler M.K., Chryssochoos J.T, et al: CTLA4- Ig prolongs survival of microencapsulated neonatal porcine islets xenografts in diabetic NOD mice. Cell transplant 6:505- 508,1997.

Smith D.K., Korbut G.S., Suarez-Pinzon WL., et al: Interleukin- 4 or interleukin-1 O expressed from adenovirus- transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation 64:1030-

, 1997.

Tripp C.S., Wolf S.F., Unanue E.R: Interleukin 12 and tumor necrosis factor are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with Iisteriosis, and interleukin 10 is a physiologic

antagonist. Proc. Nat. Acad. Sci. USA 90:3725- 3729,1993.

Yang X., Michie S., et al: The role of ce11adhesion molecules in the development of IDDM. Diabetes 45:705-710, 1996.

Tafuri A, Bowers WE., et al: High stimulatory activity of dendritic cells from diabetes-prone BioBreeding/Worcester rats exposed to macrophage-derived factors. J. Clin. Invest. 91 :2040-2048, 1993.

Vives M., Soldevila G., et al: Adhesion molecules in human islet [i cells: de novo induction of ICAM-1 but not LFA-3. Diabetes 40: 1382-1390, 1991.

Martin S., Heidenthal E. et al: Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia 41:1298-1303,1998.

Steptoe R.J., Thomson A.W.: Dendritic cells and tolerance induction. Clin. Exp. Immunol. 105:397-402, 1996.

Lu L., Lee A. et al. Transduction of dentritic cells with adenoviral vectors encoding CTLA4-lg markedly reduces their allostimulatory activity. Transplantation Proceedings 31:797, 1999.

Linsley P.S., et al: Immunosupression in vivo by a soluble form ofthe CTLA-4 cell activation molecule. Science 257:793- 795, 1992.

Starzl TE., Murase N., et al: Regulation of immune reactivity and tolerance migration and localization: With particular reference to allo- and xenotransplantation. Transp!antation Proceedings 31 :763-768, 1999.

Pratt J.C., Sadwasdikosol S. et al: Positive and negative signaling pathways. Transplantation Proceedings 31:772-774, 1999.

Kenyon N.S., et al: Long-term survival and funetion of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. Natl.Acad. Sci. 96:8132-817,1999.

Kenyon N.S., Fernandez L.A., et al: Long-term survival and funetion of intrahepatic islet allograft in baboons treated with humanized anti-CD 154. Diabetes 48: 1473-1481, 1999.

Stuart P.M., Grifith TS, Usui N., Pepose J., Yu X., Ferguson TA.: CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 99:396-402, 1997.

Fandrick F., Lin X., Zhu X., Kloppel G., Parwaresch R, Kremer B: CD95L confers immune privilege to liver which are spontaneously accepted. Transplant Proc. 30:1057-1058,1998.

Schneider P., Thome M., Burns K., Bodmer I.L., Hofmann K., Kataoka T, Holler N. Tschopp J.: Trail receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappa~. Immunity 7:831-836,1997.

Wajant H., Johannes F.J., Haas E., Siermienski K, et al: Dominant-negative FADD inhibits TNFR60, Fas/Apol and TRAIL-RA/Ap02-mediated cell death but not gene induction. Curro BioI8:113-116, 1998.